GB Sciences Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

Late quarterly filing notification for Q2 2026

Late quarterly filing notification for Q1 2026

Late annual filing notification for FY 2025

ended 12/31/24 Q3

Late quarterly filing notification for Q3 2025

Prospectuses and Registrations Filter

Prospectus supplement

Exempt offering of securities

Prospectus supplement

Exempt offering of securities

Prospectus supplement

Ownership Filter

Ordower Lawrence Burton

Moody Robert Jr

News Filter

Signs Licensing Deal With EndoPure Life Sciences for 5% Gross Sales Royalty & Sponsorship of First-In-Human Trial for Their Cannabinoid-Based Parkinson’s Drug

Change in Directors, Officers or Compensation

Unregistered Sales of Equity Securities, Change in Directors, Officers or Compensation

Change in Directors, Officers or Compensation

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC